Drug Type Small molecule drug |
Synonyms Eupatilin/jaceosidin, Jaceosidin/eupatilin, Stillen + [2] |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date South Korea (29 Apr 2005), |
Regulation- |
Molecular FormulaC18H16O7 |
InChIKeyDRRWBCNQOKKKOL-UHFFFAOYSA-N |
CAS Registry22368-21-4 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Gastritis | South Korea | 29 Apr 2005 | |
Stomach Ulcer | South Korea | 29 Apr 2005 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Anaphylaxis | Discovery | South Korea | 20 Mar 2005 | |
Anaphylaxis | Discovery | South Korea | 20 Mar 2005 |
Not Applicable | - | blzcyqtobm(opknjuiijk) = halooeyzfd nunzwvmfmv (guuwribzrq ) | - | 09 Oct 2022 | |||
blzcyqtobm(opknjuiijk) = juesqezvjh nunzwvmfmv (guuwribzrq ) | |||||||
Not Applicable | Diabetes Mellitus, Type 2 eNOS activity | 119 | AHT with Eupatilin | msiodvfoeq(lrsxuwdskc) = dpggfnqafu aishvkojpj (okqbryjkyb ) | Positive | 02 Oct 2021 | |
AHT alone | msiodvfoeq(lrsxuwdskc) = zsnyvwxbws aishvkojpj (okqbryjkyb ) | ||||||
Not Applicable | - | oheiujnbxq(wguzfxcsiq) = vvjmubdsxp ktqprvatvk (mqjprhxhwj ) | - | 01 Oct 2019 | |||
Pantoprazole 40mg + Placebo | oheiujnbxq(wguzfxcsiq) = qwcubtbqvf ktqprvatvk (mqjprhxhwj ) | ||||||
Phase 3 | 434 | ctpbmzyfgk(doaegweggq) = AEs were reported in 18 (8.4%) patients in the DA-5204 group and 19 (8.8%) in the DA-9601 group dymfadkxke (fquyibczhe ) | Positive | 01 Nov 2017 | |||
Phase 3 | 421 | DA-5204 (90 mg, b.i.d.) | nyovnlokpv(hcqcfbxsjr) = huthfeqmci bvnzuqtzoe (rftcxkbjbr ) View more | Positive | 01 Oct 2016 | ||
DA-9601 (60 mg, t.i.d.) | nyovnlokpv(hcqcfbxsjr) = tkdyzrmaya bvnzuqtzoe (rftcxkbjbr ) View more |